chr20-46174874-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021248.3(CDH22):c.2119G>A(p.Gly707Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000846 in 1,358,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021248.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH22 | NM_021248.3 | c.2119G>A | p.Gly707Ser | missense_variant | Exon 12 of 12 | ENST00000537909.4 | NP_067071.1 | |
CDH22 | XM_011528994.3 | c.2119G>A | p.Gly707Ser | missense_variant | Exon 12 of 12 | XP_011527296.1 | ||
CDH22 | XM_047440373.1 | c.1879G>A | p.Gly627Ser | missense_variant | Exon 10 of 10 | XP_047296329.1 | ||
CDH22 | XM_024451966.2 | c.1756G>A | p.Gly586Ser | missense_variant | Exon 12 of 12 | XP_024307734.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000729 AC: 11AN: 150956Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000698 AC: 6AN: 85994Hom.: 0 AF XY: 0.0000399 AC XY: 2AN XY: 50100
GnomAD4 exome AF: 0.0000861 AC: 104AN: 1207708Hom.: 0 Cov.: 37 AF XY: 0.0000902 AC XY: 53AN XY: 587558
GnomAD4 genome AF: 0.0000729 AC: 11AN: 150956Hom.: 0 Cov.: 31 AF XY: 0.0000543 AC XY: 4AN XY: 73702
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2119G>A (p.G707S) alteration is located in exon 11 (coding exon 11) of the CDH22 gene. This alteration results from a G to A substitution at nucleotide position 2119, causing the glycine (G) at amino acid position 707 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at